Nanalysis Scientific Corp. develops and sells magnetic resonance technology products globally. The company shows a moderate gross margin of 26.1%, indicating some pricing power, but faces concerns with a negative net margin of -6.9% and low profitability metrics, including a ROE of -5.4%. The current ratio of 1.03 suggests adequate liquidity, but a quick ratio of 0.72 raises concerns about immediate financial health. Overall, while there are strengths in product development, the financial metrics highlight significant challenges that could impact future growth.
Loading financial metrics...
Company posted a loss of $-4.2M over the last year, representing 10.3% of revenue.
Debt of $14.0M is 25.9x the company's cash position of $540K.
Revenue decreased 6.2% year-over-year from $43.0M to $40.4M.
Operating margin expanded by 3.6pp, demonstrating strong operational leverage.
Operating cash flow surged 58.1% YoY, indicating strong cash generation capability.
Free cash flow increased 3498.0% YoY, enhancing capital allocation optionality.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Scientific & Technical Instruments companies of a similar size
Based on 2026-Q2 (June 30, 2026)